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Machine learning methods continue to show promise in the analysis of data from genetic association studies
because of the high number of variables relative to the number of observations. However, few best practices exist
for the application of these methods. We extend a recently proposed supervised machine learning approach for
predicting disease risk by genotypes to be able to incorporate gene expression data and rare variants. We then
apply 2 different versions of the approach (radial and linear support vector machines) to simulated data from
Genetic Analysis Workshop 19 and compare performance to logistic regression. Method performance was not
radically different across the 3 methods, although the linear support vector machine tended to show small gains in
predictive ability relative to a radial support vector machine and logistic regression. Importantly, as the number of
genes in the models was increased, even when those genes contained causal rare variants, model predictive ability
showed a statistically significant decrease in performance for both the radial support vector machine and logistic
regression. The linear support vector machine showed more robust performance to the inclusion of additional
genes. Further work is needed to evaluate machine learning approaches on larger samples and to evaluate the
relative improvement in model prediction from the incorporation of gene expression data.Background
Breakthroughs in genome-wide sequencing continue to
motivate the development of novel methods to identify
risk factors for complex diseases. Machine learning
methods (MLMs) are statistical algorithms that allow a
computer to learn from one data set (selection set) and
make inferences to other data of the same nature. MLMs
lend themselves to the genetic analysis of diseases with
multiple and complex risk factors, because of the high-
dimensional nature of the data. Despite some initial* Correspondence: nathan.tintle@dordt.edu
3Department of Mathematics, Statistics and Computer Science, Dordt
College, 498 4th Ave NE, Sioux Center, IA 51250, USA
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zeapplications of machine learning to genetic association
studies with sequence data [1, 2], MLMs remain outside
of the mainstream for evaluating genotype–phenotype
association.
We extend a recently proposed supervised machine
learning approach [3] in order to further understand the
behavior and performance of MLMs on sequence data.
We incorporated a recent statistical model proposed for
the joint analysis of gene expression data and genotype
data in evaluating disease risk [4], along with explicit
consideration of the analysis of rare variants using a
collapsing (burden) approach [5].le is distributed under the terms of the Creative Commons Attribution 4.0
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Data
Genetic Analysis Workshop 19 (GAW19) provided real
DNA sequences and simulated phenotype data on individ-
uals from complex pedigrees. Two-hundred independent
simulations of a dichotomous hypertension variable were
provided. All simulations were based on the same genetic
disease model, and thus have the same set of known,
causal variants across a set of fixed genotypes. Our
analyses considered different subset of the 200 simulated
versions of the variable.
Each simulated version of the hypertension variable is
an indicator variable for an individual’s hypertensive sta-
tus (0 = not hypertensive or 1 = hypertensive). By sum-
ming across multiple, independent simulations, we
created a more specific disease status variable. In par-
ticular, we computed 5 different modified hypertension
status variables, Yi,m as:

















where, l = number of times individual i is classified as
hypertensive out of m independent simulation replicates.
We considered values of m = 5, 25, 50, 100, and 150 in
our analyses. This resulted in 80, 70, 66, 64, and 65 indi-
viduals with Yi,m = 1 out of the total sample of n = 637
individuals for m = 5, 25, 50, 100, and 150, respectively.
Additionally, we used a series of covariates, including
age, sex, pedigree structure, and smoking status. Because
evaluating the potential gain in predictive ability when
using gene expression data to predict disease risk was a
key goal of our study, we limited our analysis to n = 637
individuals for whom gene expression data was available.
Gene expression data was obtained from peripheral
blood mononuclear cells at the first examination period
using an Illumina whole-genome expression array.
Analysis
Following previous work on this data set [3], we use
different combinations of the first 150 simulated data
sets (SIMPHEN.1 to SIMPHEN.150) to select genes of
interest and used 3 other, arbitrarily chosen, simulated
data sets (SIMPHEN.197 to SIMPHEN.199) from the
remaining simulated sets, as classification data sets. We
now provide details of the selection and classification
steps.
Gene selection method
We started by fitting the following model below (1) for
each gene in the selection data set. The model is an
extension of a recently proposed model [3] but using (a)variant collapsing across the gene and (b) adding main
effect and interaction terms for gene expression data.
logit Pr Y ¼ 1ð Þð Þ ¼ Ageþ Sexþ Smoke þ Age
 Sexþ Pedigreeþ Gi þ Si
þ GiSi ð1Þ
where Y = 1 indicates that an individual is hypertensive,
Sex and Smoke are indicator variables for the respon-
dent’s Sex and Smoking status, respectively, and Age is a
continuous measure of the respondent’s age. Pedigree
information was incorporated into the model via the use
of an indicator variable for each distinct pedigree as has
been done previously with this data set [3]. Gi is a con-
tinuous measure of gene expression at the gene of inter-
est, i, and Si is an indicator of the presence of any rare
(minor allele frequency <5 %) alleles at any location
within the same gene of interest, i; collapsing is done in
the spirit of combined multivariate and collapsing [5].
We also include a gene–single nucleotide polymorphism
(SNP) interaction term, GiSi, as recently proposed [4], to
account for potential interactions between expression
level and genotype on hypertensive status. Following
earlier work exploring the use of support vector ma-
chines on this data set [3], the p value for each gene
containing at least 1 causal variant, as well as randomly
selected genes not containing any causal variants, were
computed using the model above.
Classification method
Predictions of disease status were made using 1 of 3
approaches.
Logistic regression
The first approach, logistic regression (LR), included 1
or more of the most strongly associated causal and/or
non-causal genes from the selection step (based on
smallest p values), and applied eq. (1), with separate
terms for each gene, to the classification data set. The
result is a LR model which can be used to make predic-
tions of disease status for each individual.
Support vector machine approaches
The final 2 classification approaches used support vector
machines (SVMs) to make classifications. The svm() and
tune.svm() functions in R [6] were used to make predic-
tions. In particular, the SVM was provided the prediction
model (including 1 or more genes), the selection data set
and either a linear or radial basis kernel (the 2 different
SVM approaches used). Tenfold cross-validation was
used to estimate the kernel hyperparameters, γ and C,
and probabilistic estimations of the likelihood of hyper-
tension were allowed.
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We considered 315 different combinations of gene lists,
phenotype simulations, and gene expression data values.
In particular, linear SVM, radial SVM, and LR were
applied to lists of the top 1, 5, or 10 causal genes identi-
fied at the selection stage, or to the top 5, 15, or 50 non-
causal genes, or to models containing no genetic data.
To evaluate the impact of variation in gene expression
data, which was the same for each person in both the
selection and classification data sets, we added random
noise (a uniform [−k, k] random variable) to observed
gene expression values where k = 0, 0.01, and 0.1 (3 com-
binations) in the selection data. Thus, we explored a
total of 315 combinations (7 gene lists × 3 levels of gene
expression noise × 3 classification data sets × 5 different
phenotypes (values of m) = 315). For each combination,
all 3 classification models were applied, with area under
the receiver operating characteristic curve (AUC) com-
puted for each model-combination based on which indi-
viduals were actually hypertensive in the data set.
Follow-up analyses
Two small-scale follow-up analyses were conducted.
Follow-up #1
The first follow-up analysis evaluated the value added of
gene expression data by fitting models without gene
expression data (no gene expression main effect, Gi, or
interaction term, GiSi, in the model [eq. 1]) were run on
SimPhen.197 with m = 5 for 1, 5, and 10 causal genes.
All 3 classification methods (LR, radial SVM, and linear
SVM) were used.
Follow-up #2
The second follow-up analysis looked at the impact of
the choice of phenotype. Because the collapsed pheno-
type defined earlier (see Data above) only identifies
slightly more than 10 % of subjects as hypertensive (a
fairly specific diagnostic measure), we also implemented
a more sensitive measure of hypertension. The more
sensitive measure of hypertension diagnosis, Zi,m is de-
fined as:

















where l = number of times individual i is classified as
hypertensive out of m independent simulation replicates.
We considered values of m = 5, 25, 50, 100, and 150 in
this follow-up analysis. This follow-up analysis used k =
0 for SIMPHEN.197 and considered 1, 5, and 10 causalgenes for all 3 classification methods (LR, radial SVM,
and linear SVM).
Results
Overall, LR, linear SVMs, and radial SVMs yielded
similar values of AUC across all 315 settings (Fig. 1)
with baseline AUC values (no genetic data, covariates
only) of 0.777 (linear), 0.771 (radial), and 0.771 (logistic)
on average. Linear SVM tended to outperform both other
methods by a slight margin overall (mean improvement
vs. LR = 0.009 [SD = 0.016]; mean improvement vs. radial
SVM= 0.012 [SD = 0.016]), differences which were statisti-
cally significant (p <0.001 in both cases). Linear SVM also
provided the largest AUC of the 3 methods in the majority
of cases examined here (54.9 % = 173/315). Radial SVM
(largest AUC in 19.7 % = 62/315 of cases) and LR (largest
AUC in 25.4 % = 80/315 of cases) yielded the best AUC in
approximately equal numbers in the remainder of cases.
To better understand how different variables affected
performance of the 3 different prediction methods, we
used a multiple regression model predicting AUC by
number of causal genes, number of noncausal genes, k
(gene expression noise), and m (number of phenotypes
being collapsed). Separate models were run for each of
the 3 different prediction methods. Results summarizing
estimated effects of each model parameter and signifi-
cance are shown in Table 1.
In all 3 models, as expected, adding more noncausal
genes to the model reduced the AUC. However, the im-
pact of including noncausal genes was approximately
twice as much for LR (−1.7 × 10−3) as compared to either
SVM approach (radial: −9.8 × 10−4; linear: −1.0 × 10−3).
Adding more causal genes to the model also reduced the
AUC, although the impact was approximately 5 times
less for the linear SVM approach (−1.6 × 10−4) and not a
statistically significant effect (p = 0.47), as compared to
radial SVM (−8.2 × 10−4) and LR (−7.5 × 10−4), where the
impact of adding causal genes was similar to the
addition of noncausal genes and highly statistically
significant (p <0.001 in both cases). Finally, all 3 models
had reduced predictive ability (lower AUC) in the pres-
ence of increased noise in the gene expression data (k)
and increased numbers of simulations (m) collapsed to
create the hypertension variable.
Follow-up analysis #1
Table 2 highlights the impact of including or not includ-
ing gene expression data for a subset of parameter set-
tings (SIMPHEN.197, m = 5). Changes in the AUC were
relatively small and variable for all 3 prediction methods.
Follow-up analysis #2
Use of a more sensitive phenotype variable (see Methods:
Follow-up analyses above) yielded improved AUC values
Fig. 1 Overall performance (AUC) of the 3 classification approaches across 315 different situations. All 3 methods performed fairly similarly on
AUC overall. Linear SVM tended to slightly outperform both other methods across the 315 different settings investigated
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AUC were 0.03 (radial: 95 % confidence interval [CI]: 0.01,
0.08), 0.05 (linear: 95 % CI: −0.01, 0.19), and 0.01 (LR:
95 % CI: 0.00, 0.04) across the 15 settings considered in
this follow-up analysis.
Discussion
We have demonstrated a supervised MLM to integrate
gene expression data and rare variants in an analysis of
disease risk. Linear SVM performed well, likely because
of its ability to more robustly handle larger numbers of
features (variable) compared to nonlinear SVM and LR.
Linear SVM showed the most robustness to the inclu-
sion of both noncausal and causal genes. Notably, AUC
decreased for all methods when including additional
causal and non-causal genes. This was likely a result of
the addition of more variation (noise) than effect (signal)
when adding additional genes, regardless of whether or
not the genes were causal. Further research is needed to
investigate the limits of MLMs with regards to how
many genes/features maximizes performance.
While although we sought to potentially increase the
predictive ability of the models by evaluating an increas-




Gene expression noise (k) −3.5 × 10−2 (1.2 × 10−2)**
Number of collapsed phenotypes (m) −4 × 10−5 (1.1 × 10−5)***
Number of causal genes −7.5 × 10−4 (1.7 × 10−4)***
Number of random genes −1.7 × 10−3 (3.6 × 10−5)***
Model r2 88.4 %
β^ , the estimated coefficient in the regression model; SE, the estimated standard err
Regression models predicted AUC by 4 different model parameters for each of the
Statistical significance of the estimated regression coefficients is indicated by asteriin lower predictive ability for all 3 machine learning
approaches. Our follow-up analysis showed promise in
that increasing the sensitivity of the hypertension variable
tended to increase AUC for all 3 methods. This may serve
to underscore the fact that optimal statistical study design
would have equal numbers of cases and controls when
comparing groups on a fixed sample size budget; a par-
ticular concern for SVM methods, although some solu-
tions exist [7]. However, whether to use broad (sensitive)
or narrow (specific) phenotype definitions remains an
important and open question in statistical genetics.
Finally, the inclusion of gene expression data with
genotype data at the same loci, generally reduced pre-
dictive ability. However, in a follow-up analysis when
we compared models with and without gene expression
data, but both containing genotype data, results were
inconclusive with regards to model predictive ability
improvements because of the addition of gene expres-
sion data. More work is needed to develop models
incorporating gene expression data that directly con-
nect biological mechanisms with the statistical model.
We note that in this data set, it is unclear whether the
gene expression data actually would be beneficial in





−6.4 × 10−2 (2.0 × 10−2)** −3.3 × 10−2 (1.7 × 10−2)
−5.49 × 10−6 (1.7 × 10−5) −4.4 × 10−5 (1.5 × 10−5)**
−8.2 × 10−4 (2.7 × 10−4)** −1.6 × 10−4 (2.3 × 10−4)
−9.8 × 10−4 (5.6 × 10−5)*** −1.0 × 10−3 (4.8 × 10−5)***
50.7 % 62.5 %
or of the coefficient
3 methods separately
sks (***p <0.001, **p <0.01)
Table 2 Comparing model AUC with and without gene expression data
Number of
causal genes
LR Radial SVM Linear SVM
Without gene exp. With gene exp. Without gene exp. With gene exp. Without gene exp. With gene exp.
1 0.775 0.772 0.764 0.764 0.767 0.772
5 0.772 0.773 0.755 0.760 0.759 0.770
10 0.785 0.778 0.739 0.755 0.776 0.770
Model AUC is reported in the table for SIMPHEN.197, k = 0 (when expression data was included) and m = 5. The table shows that the inclusion of gene expression
data had little-to-no impact on the AUC in this data set
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lated data sets to quantify the size of effects needed in
expression data to be detected by MLMs.
Some additional limitations of our analysis are worth
noting. First, although we followed previous researchers
in how we incorporated pedigree status in the model [3],
more sophisticated approaches may yield better per-
formance (eg, extreme phenotype sampling). Second, the
sample size we used was quite small and so the power is
likely quite limited for any approaches and consideration
of the performance of these methods on larger samples
should be considered by future researchers in this area,
to see if larger improvements in AUC can be realized.
However, despite the decreasing cost of sequencing data,
small sample sizes will likely to continue to be a limiting
factor in genetic analysis for the short term. Third, we
only considered intragenic SNPs, even though intergenic
SNPs may be associated with gene expression levels and
should be considered in follow-up studies. Finally, the
approach we used to compare methods used different
simulated data sets provided by the Genetic Analysis
Workshop organizers; these data sets, however, have
fixed genotypes. Additional simulation studies using with
variable genotypes are needed.Conclusions
Supervised MLMs continue to be an enticing alternative
to mainstream statistical techniques for elucidating
genotype-phenotype relationships in large, complex data
sets. Further work is needed to develop best practices
for such approaches and quantify performance gains vs.
standard approaches.Acknowledgements
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